Relapsing Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: CDP323 Biomarker Study [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 biomarker study of CDP323 in relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Transition to Rebif New Formulation [Phase 3]
Phase 3 trial update on transitioning to a new Rebif formulation for relapsing multiple sclerosis; results were posted in July 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Biogen-sponsored clinical trial has completed comparing Avonex and Rebif to determine if they work comparably in relapsing multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Rebif New Formulation (RNF) Quality of Life (QOL) Study [Phase 3]
Phase 3 study evaluating Rebif New Formulation (RNF) for quality of life in relapsing multiple sclerosis; completed with results posted in 2…